智通财经APP获悉，微创医疗(00853)盘中涨近17%，截至发稿，涨16.82%，报7.4港元，成交额2.45亿港元。
消息面上，近日，国家药品监督管理局局长李利今日在新闻发布会上介绍，我国医药创新活力持续增强，创新产品上市步伐不断加快;积极支持创新药械进医院、进医保;促进全球药物在中国同步研发、同步申报、同步审评、同步上市。国家药品监督管理局副局长雷平则表示，国家药监局全力促进医疗器械研发创新，推动科研成果尽快转化为创新产品。
国泰君安此前发布研报指出，公司创新业务2024H1期间继续保持高速增长，大动脉及外周介入业务营收1.10亿美元(+26.3%)，神经介入业务营收0.57亿美元(+36.5%)，结构心业务营收0.31亿美元(+26.7%)，手术机器人业务营收0.10亿美元(+117%)。该行认为，2024H1公司调整研发重心，在降低研发费用的同时提升研发效率，保障核心产品管线研发稳步推进，预计研发端竞争力有望维持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.